Update on Borderline Personality Disorder for Community Practitioners.

1. Update on Borderline Personality Disorder for Community Practitioners. Paul S. Links, MD, FRCPC Chair/Chief Department of Psychiatry, UWO

2. Disclosures • Unrestricted educational grant from Eli Lilly Canada Inc. ended in 2011, • Honorarium from Lundbeck Canada.

3. Objectives At the end of this presentation, participants will be able to: • Describe our current knowledge related to Borderline Personality Disorder (BPD), • Discuss the rationale for focusing on suicide behavior rather than diagnosis, • Characterize the general principles for psychotherapy for patients with recurrent suicide behavior.

4. What have we learned? • Review of recent findings related to borderline personality disorder

5. Prevalence: Summary of Community Surveys • Prevalence varied from 0.7-5.9% • Grant et al (2008) study required that respondent endorse the requisite number of symptoms • At least 1 of which caused social or occupational dysfunction. • Criticized as being to broad; favored prevalence closer to 1-2%.

6. Comorbidity: Summary of Community Surveys • Prevalence F=M in recent surveys, • Comorbid with anxiety, mood and substance dependent disorders, • Most characteristic – 3 or more disorders may be characteristic of individuals with BPD.

7. Consequences: Summary of Community Surveys • BPD related to marital dysfunction, marital disruption and marital violence, • BPD related to under and unemployment, • Mixed findings whether related to Axis II or comorbid Axis I disorders.

8. Diagnosis: What have we learned? • DSM-5 - No change to criteria • Affective criteria • Inappropriate intense anger or difficulty controlling anger— e.g., frequent displays of temper, constant anger, recurrent physical fights • Chronic feelings of emptiness • Affective instability due to a marked reactivity of mood— e.g., intense episodic dysphoria, irritability, or anxiety usually lasting a few hours and only rarely more than a few days

9. Characteristics of Affective Instability • Based on Experience Sampling Methodology (ESM) (Nica and Links 2009) • Higher intensity of negative mood • Greater breadth of negative affect • Frequent and abrupt mood changes • Triggering by current external events – inconclusive • Increase risk of suicide-related behaviors – mechanism is to be clarified

10. Affective Instability and Suicide-Related Behavior • Yen et al (2004) • Affective instability, identity disturbance, impulsivity predicted suicide behaviors • Affective instability predicted attempts • Links et al (2007) • Using Experience Sampling Methodology (ESM) • Mean negative mood intensity predicted daily self-reported suicide ideation and modestly related to number of suicide events in past year. • Links et al (2008) • Individuals at elevated risk for suicide behavior had high mean negative mood intensity and high mood variability

11. High mood intensity and amplitude

12. Diagnosis in Adolescent Patients • diagnosis can be made reliably • look for history over more than two years • similar phenomenology and developmental history • impaired functioning, symptomatic • predictive validity still debated • early intervention in emerging BPD – Andrew Chanen’s approach

13. Course: Summary of Prospective Follow-up Studies • BPD course related to course of anxiety and mood disorders, • Remission of BPD predicts remission of MDD, • Recurrences of MDD and predicted by no. and types of BPD criteria,

14. Course: Summary of Prospective Follow-up Studies • Absence of substance abuse/drug abuse may predict remissions in medium term (up to 6 years), • Eating disorders independent of BPD, • Long-term course less related to comorbid Axis I disorders.

15. BPD COMORBIDITY: WHICH DISORDER IS PRIMARY

16. Do Individuals with BPD Improve? • Remissions from BPD common – 99% over 16 years follow up (Zanarini et al 2011). • Remissions are stable; recurrence of BPD is uncommon (36% after 2-yr remission). • BPD criteria had similar rates and levels of decline over 10 yr. follow up (Gunderson et al 2011)

17. Studies of Course: Clinical Implications • Presence of substance use disorders closely associated with failure to remit. • Improvement in BPD lessens risk of MDE; resolution of MDE little impact on BPD.

18. Etiology of BPD: No Single Factor • Paris (2001) genetic vulnerability + exposure to psychological and social factors, • Zanarini et al (2002) 50% of BPD inpatients report significant CSA, • “Dual-brain” pathology – amygdala hyperactive + PFC insufficient inhibition.

19. Neuroimaging Studies of BPD • Structural – reduced hippocampal volume; less consistent altered amygdalar volume. • Functional – amygdalar hyperactivity with prefrontal hypoactivity. • Inconsistency related drug exposure, comorbid disorders particularly PTSD, laboratory conditions and heterogeneity of BPD • Next longitudinal/intervention studies.

20. Relationship Between Childhood Abuse (CA) and BPD • Meta analysis “small to moderate effect” in explaining BPD (Fossati et al 1999), • Zanarini et al (2002) 50% with significant history of childhood sexual abuse. • Paris concludes significant etiologic role in subgroup of BPD

21. Relationship Between CA and BPD • Childhood sexual abuse and emotional neglect uniquely related to deliberate self-harm (Gratz 2003) • Not a specific causal relationship – related to substance abuse, depression and other adult outcomes. • Gene-environment interactions.

22. Lack of Specificity: Gene-environment Interaction • “One feature of a good candidate environmental risk factor is…it should not perfectly predict the disorder outcome.” (Moffitt et al 2005) • Maltreated children with low levels of the genetic factor (monoamine oxidase A expression) more often developed conduct disorder … than children with a high levels of genetic factor (Moffitt et al 2005).

23. Lack of Change in Functioning • Zanarini et al (2011) symptom and functional recovery in 60% at 16 years follow up. • Impairment in social functioning “enduring,” • Zanarini et al (2010) vocational > social, • Functioning lacks behind symptom improvement, • Characterizing and focusing on dysfunction next step – Rehabilitation model

24. Aims of Canadian DBT Study To evaluate the clinical effectiveness and economic impact of DBT vs a rigorous control treatment

25. Study Design Conditions: DBT vs. General Psychiatric Management (GPM) Sample Size: N = 180 (90 per group) Time Frame: 1 year treatment + 2 year follow-up Assessments: • Pre-treatment • Every 4 months during 1-year treatment phase • Every 6 months during 2-year follow-up

26. Cost Treatment History:THI State of Health:EuroQol-5D Treatment Utilization: OHIP Database (provincial data base of health care utilization) Clinical Self harm: PHI, LYPC BPD symptoms: ZAN-BPD Depressive symptoms: BDI Psychopathology: SCL-90-R Interpersonal Functioning: IIP Anger: STAXI Social & Global Functioning: SAS, GAF Outcomes

27. Research Team Centre for Addiction and Mental HealthSt. Michael’s Hospital Shelley McMain, Ph.D., C. Psych. (PI) Paul Links, M.D., F.R.C.P Robert Cardish, M.D., F.R.C.P. Ian Dawe, M.D., F.R.C.P. William Gnam, M.D., F.R.C.P Adam Quastel, M.D., F.R.C.P Lorne Korman, Ph.D., C. Psych. Tim Guimond, M.D. Baycrest Centre for Geriatric StudiesUniversity Health Network David Streiner, Ph.D., C. Psych. Larry Grupp, Ph.D(consultant) Funded by grants from the Canadian Institutes of Health Research (Ref # 101123)

28. Frequency of S-H and Suicide Behaviors Treatment Phase: significant reductions in both groups (p<.001); no between group differences 2-yr Follow-up: further significant improvements in both groups (p<.0001); no between-group differences.

29. Frequency of Suicidal Behavior Treatment Phase:significant reductions in both groups (p<.001); no between group differences 2-yr Follow-up:gains made during treatment were maintained; nobetween-group differences.

30. Frequency of Self harm Behaviors Treatment Phase:Significant reductions in both groups (p<.001); no between group differences 2-yr Follow-up: additional significant reductions (p<.0001); no between-group differences.

31. Maximum Medical Risk of Suicidal/S-H Behaviors Treatment Phase: significant decreases over time for both groups (p<.001); no between group differences 2-yr Follow-up: Gains were maintained in both groups; no between group differences .

32. Emergency Room (ER) Visits • Treatment Phase: time effect (p<.001)2-yr Follow-up significant further reductions in both groups (<.0004) Assessment Points Mixed effects model, time sig

33. ER Visits for Suicidal Behavior • Treatment Phase: time effect (p<.001) • 2-yr Follow-up time effect (<.0002) Assessment Points Mixed effects model, time sig

34. Summary • DBT and GPM were efficacious across a broad range of outcomes over treatment phase • Suicide and self harm attempts: frequency and medical risk • Health care utilization: emergency room use and psych hospital days • General symptoms: Depression, anger, interpersonal functioning, symptom distress • BPD symptoms

35. Summary Two years post treatment, DBT and GPM had further improved or maintained gains Further improvements: • Frequency of suicidal and NSSI behaviors • Emergency room visits • Anger, interpersonal functioning, symptom distress, • Depression (GPM only) • Overall quality of life Maintenance of gains: Psych hospital days, BPD symptoms, lethal risk of suicidal behaviors

36. Shared Elements of GPM and DBT • Manualized and adherence measured • Allegiance to approach • Focus on emotion processing deficits • Active to ensure engagement • Demonstrate empathy and validation • Provide education about BPD • Participation in supervision group required

37. Managing Suicide Risk by Focusing on Suicide Behavior • Linehan (2008) “no published randomized trial has shown that interventions targeting mental disorders result in significant reductions in suicide attempts or death by suicide.” • “treatments need to address suicidal behavior…” • GPM addresses risk of suicide behavior (1st International Congress on Borderline Personality Disorder, Berlin, Germany, July, 2010).

38. Managing Suicide Risk by Focusing on Suicide Behavior • Prospective study of BPD and recently discharged patients, • Consistent with risk factors in high risk settings: • Not diagnosis • Recent attempts • Number of attempts • Medical lethality of attempts.

39. Managing Suicide Risk by Focusing on Suicide Behavior • Are suicide and disorders the result of common or separate causal chains? • Mishara – Suicide caused by consequences of having a mental disorder • Could psychotherapy management focus on suicide behavior across disorders?

40. Common Elements for the Psychotherapy Management of BPD • Francesca Schiavone & Dr. Paul Links Child Abuse & Neglect (in press) • Review of previous expert reviews • Experience from DBT vs GPM comparison.

41. Coherent Treatment Model • Well structured and clearly focused approach increases therapist confidence • Patient is not blamed for their difficulties • General Psychiatric Management : Disrupted Attachment/Emotional Dysregulation -> Self Injurious Behavior

42. Active Therapeutic Stance • Must addressed the need for an active therapeutic stance – several aspects: • Attention to treatment framework • Therapist emotionally and mentally engages with patient • Creation of a strong attachment relationship between therapist and patient

43. Balance between Validation and Change • Change-oriented interventions can seem aversive and invalidating. • Validation “[affirms] existing thoughts, feelings or behaviors of the patient” (Weinburg et al, 2010) • Balancing the two builds rapport and helps the patient to tolerate change

44. Fostering Self-Agency • Self-Agency: the sense that that the environment is altered by and responsive to the individual’s actions and intentions. • A “co constructive relational process” between therapist and patient restores a sense of self agency (Knox, 2011) • Therapy allows the patient to experience expressing self-agency without being rejected

45. Connecting Actions and Feelings • Psychoeducation on emotional dysregulation and self injurious behavior • Patient is encouraged to objectively observe and recognize emotions and identify early warning signs of self injurious behavior

46. Differentiating Lethal and Non Lethal Self Injurious Behavior • Patients will have some degree of chronic ideation • Focus on situations which create acute-on-chronic risk (risk assessment) • Detailed safety planning

47. Developing a safety plan:Adapted from Stanley B; Brown GK. Safety planning intervention: A brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice. 2012:19: 256-264 • Develop when patient not in crisis, • Complete all the steps as shown in video • Step 1: Warning signs:Warnings signs that are proximal triggers to crisis events • Step 2: Coping using distraction or soothing strategies • Step 3: Social situations and/or people that can help distract me: • Step 4: People who I can ask for help (note if a person is unhelpful when you are in crisis) • Step 5: Professionals or agencies I can contact during a crisis: • Making the environment safer: • Plan is meant to be modified and revised over time, • The plan should be shared with significant others and other care providers (primary care physician). • *

48. Therapist Access to Supervision • Patients who self injure can be especially challenging to work with • Therapists may experience strong negative countertransference • Supervision increases treatment coherence while reducing therapist stress

49. Treating BPD in Clinical PracticeA. Bateman AJP June 2012 • Improved prognosis over last 2 decades, • General treatment of TAU improved or less harmful, • Examples: • DBT vs TFP vs Supportive psychotherapy (Clarkin et al) • CAT vs good clinical care (Chanen et al) • MBT vs structured clinical management (Bateman & Fonagy)

50. Treating BPD in Clinical Practice Shared characteristics: • Structured for common problems, • Encourage activity and self-agency for patients, • Focus on emotion processing, • Model of pathology, • Active stance by therapist.